Archer Materials Limited

AXE

AU000000AXE7

Semiconductors

Market Closed - Australian S.E. Other stock markets 07:10:51 17/07/2024 BST			5-day change	1st Jan Change
0.28 ^AUD	0.00%		-26.32%	-26.32%

07-15	Archer Materials Promotes Engineering Manager to Technology Chief; Shares Fall 19%	MT
07-12	Mohammad Choucair to Step Down as Chief Executive Officer of Archer Materials Limited in January 2025	CI

Archer Materials Limited - Management restructure

July 15, 2024 at 10:03 am

Archer Materials Limited ('Archer', the 'Company', 'ASX: AXE'), a semiconductor company advancing the quantum technology and medical diagnostics industries, announces the following management and leadership changes, following last Friday's announcement of the resignation of CEO Dr Mohammad Choucair.

Appointment of Chief Technology Officer

Dr Simon Ruffell has been promoted to Chief Technology Officer ('CTO') to ensure a smooth transition and the continued growth of the Company's two key projects. Dr Ruffell is well qualified for the role of CTO. He has a PhD in Physics from the University of Western Ontario and a Masters of Electronic and Electrical Engineering (first class) from the University of Surrey, UK. Simon joined Archer in February 2024 as Engineering Manager, responsible for managing and progressing both the quantum and biosensor teams and projects. Over this time Simon has taken on the leadership of the development streams for these projects, and is well placed to continue to lead these activities going forward. Simon has 20 years of international experience working on technology projects and managing multi-functional teams, including hardware, process and software engineering teams. Before joining Archer, Simon was a Principal Hardware Engineering Manager at Microsoft, a Senior Manager at Applied Materials and Semiconductor, and Quantum Engagement Manager at the University of Sydney.

Strong leadership to drive Archer's progress

Greg English will remain as Executive Chairman, and will work closely with Simon Ruffell to ensure the continued development of Archer's quantum and biochip projects. In addition, Archer's broader leadership team and advisory board, which has deep semiconductor industry experience gained across companies like Intel, Silanna, Altium, and CSIRO, is well placed to ensure the Company continues on its path to create transformational technology solutions to complex global challenges.

Archer's Executive Chairman, Greg English, said, 'Archer is fortunate to be in a position where its leaders have deep experience across the semiconductor and quantum sectors, with leading global technology organisations. I have complete faith in Simon and the wider Archer team to advance the very exciting development pathways of the 12CQ qubit and the Biochip technologies.

Contact:

Eric Kuret

Tel: +61 417 311 335

Email: eric.kuret@automicgroup.com.au

Tristan Everett

Tel: +61 403 789 096

Email: tristan.everett@automicgroup.com.au

About Archer

Archer is a technology company that operates within the semiconductor industry. The Company is developing advanced semiconductor devices, including chips relevant to quantum computing and medical diagnostics. Archer utilises its global partnerships to develop these technologies for potential deployment and use across multiple industries. www.archerx.com.au

Latest news about Archer Materials Limited

Archer Materials Promotes Engineering Manager to Technology Chief; Shares Fall 19%	07-15	MT
Mohammad Choucair to Step Down as Chief Executive Officer of Archer Materials Limited in January 2025	07-12	CI
Archer Materials' Biochip gFET Designed on Six-Inch Wafer in Spain; Shares Rise 3%	06-17	MT
Archer Materials Develops Single Chip Integrated Pulsed Electron Spin Resonance Microsystem; Shares Surge 23%	03-25	MT
Archer Materials Limited and Ecole Polytechnique Federale de Lausanne Co-Develop a Single Chip Integrated Pulsed Electron Spin Resonance Microsystem	03-25	CI
Archer Materials Limited(ASX:AXE) dropped from S&P/ASX Emerging Companies Index	03-17	CI
Archer Materials Limited Designs Miniaturised Version of Biochip Biochip Graphene Field Effect Transistor Chip	03-15	CI
Archer Materials Miniaturizes Design of Biochip gFET Chip; Shares Up 5%	03-11	MT
Archer Materials Narrows Fiscal H1 Loss as Share-based Payments Expense Declines	02-16	MT
Archer Materials Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-16	CI
Archer Materials Secures R&D Tax Rebate for Fiscal Year 2023	11-14	MT
Archer Materials Limited Demonstrates Multiplexing Readout for its Advanced Biochip Graphene Field Effect Transistor Device	11-01	CI
Archer Materials Limited(ASX:AXE) dropped from S&P Global BMI Index	18/09/23	CI
Australian Shares Edge Up as US Inflation Rises, But US Fed Rate Hike Expectations Remain Unchanged	14/09/23	MT
Archer's gFET Biochip Design for Advanced Sensing Receives Validation from Commercial Foundry Partner	14/09/23	MT
Archer Materials Limited Reports Earnings Results for the Full Year Ended June 30, 2023	24/08/23	CI
Archer Materials Limited Further Enhances Biochip gFET Design for Advanced Sensing and Send to Commercial Foundry Partner	31/07/23	CI
Archer Materials Submits Sensor Technology Design for Scalability Verification	13/07/23	MT
Archer Materials Limited Transfers Biochip Graphene Sensor Technology Design to A Commercial Fab to Verify Scalability	13/07/23	CI
Wildfires halt mining operations in Canada	06/06/23	RE
Archer Materials Joins World Economic Forum C4IR Partnership	22/05/23	MT
Archer Materials Limited(ASX:AXE) dropped from S&P/ASX All Ordinaries Index	20/03/23	CI
Archer Materials Limited Provides Shareholders an Update on the Progress of Its 12CQ Chip Development	15/03/23	CI
Archer Materials Limited Achieves Electronic Control of Biochip gFET Sensitivity	10/03/23	CI
Archer Materials Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24/02/23	CI

Chart Archer Materials Limited

Duration

Period

More charts

Company Profile

Archer Materials Limited is a technology company, which operates within the semiconductor industry. It is engaged in developing advanced semiconductor devices, including chips relevant to quantum computing and medical diagnostics. Its principal activities include technology development, including its quantum computing qubit processor chip (12CQ chip) and lab-on-a-chip biochip technology and utilizing semiconductor technology development infrastructure and facilities, research, and development to support research activities. It focuses on advancing quantum computing and miniaturizing medical labs onto a chip. It designs and integrates materials for operating qubits in quantum technologies and building graphene transistors for enhanced biosensing. Its development spans qubit processors for practical quantum computing technology, and lab-on-a-chip biosensors for integrated bioelectronics. It develops its biochip for digitizing biologically relevant signals like those from viruses.

Sector

Semiconductors

Calendar

17/09/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Semiconductors

	1st Jan change	Capi.
ARCHER MATERIALS LIMITED	-26.32%	47.97M
NVIDIA CORPORATION	+155.16%	3,105B
TSMC (TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY)	+77.91%	838B
BROADCOM INC.	+51.74%	788B
QUALCOMM, INC.	+44.95%	234B
ARM HOLDINGS PLC	+137.90%	186B
TEXAS INSTRUMENTS INCORPORATED	+21.21%	188B
INTEL CORPORATION	-31.66%	146B
MICRON TECHNOLOGY, INC.	+49.39%	141B
ANALOG DEVICES, INC.	+22.55%	121B